E
Regen BioPharma, Inc. RGBP
$0.026 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -28.59% 84.16% -255.69% 18.49% -31.15%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -272.09% 193.02% 186.36% 1,677.78% --
Total Other Non-Cash Items 18,161.54% -- -- -39.16% --
Change in Net Operating Assets -620.85% -3.62% 2,077.98% -202.36% -504.92%
Cash from Operations 67.56% 51.65% 59.09% -536.32% -98.39%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -86.72% --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -64.17% -36.83% -60.31% -38.94% --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 100.00% 103.45% -117.14% -150.79% 81.26%